Company Filing History:
2 out of 230 
2 out of 5 Years Active: 2025
Title: Laurel Kathryn Mcgrane: Innovator in Pharmaceutical Development
Introduction
Laurel Kathryn Mcgrane is a prominent inventor based in Saint Louis, MO (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating human diseases. With a total of 2 patents, her work has garnered attention in the scientific community.
Latest Patents
Mcgrane's latest patents include innovative compounds such as substituted biphenyl or phenylheteroaryl-mannosides, which serve as antagonists of FimH. These compounds are disclosed for their potential application as pharmaceuticals in treating diseases like urinary tract infections. Additionally, she has developed new C-mannoside compounds and compositions, further contributing to methods of inhibiting FimH activity in human subjects.
Career Highlights
Throughout her career, Mcgrane has worked with notable companies, including GlaxoSmithKline Intellectual Property Development Limited and Fimbrion Therapeutics, Inc. Her expertise in pharmaceutical development has positioned her as a key player in the industry.
Collaborations
Some of her notable coworkers include Michael Joseph Bishop and James Walter Janetka. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Laurel Kathryn Mcgrane's contributions to pharmaceutical innovation highlight her dedication to improving human health through her inventions. Her work continues to inspire future advancements in the field.